Aaron Mitchell is an Oncology physician.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics need a complete publication history and a confident author match. We omit them when either check fails. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
57.7%Anti-androgens25.3%Erleada59%Nubeqa41%Part D<11 patientsCytochrome P450 17A1 Inhibitor16.5%Abiraterone Acetate100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
31.3%Corticosteroid31.3%Prednisone100%Part D≥17 patientsGenitourinary & hormones
11%alpha-Adrenergic Blocker11%Tamsulosin Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
10 NIH research awards on record, funded 1988–2026 per NIH RePORTER. The latest:
- Access and Outcomes of Radioligand Therapy for US Veterans with Prostate Cancer
Sloan-Kettering Inst Can Research
FY2026$708,377R01CA318433 - Understanding the Importance of Industry Relationships for Cancer Care Quality, Outcomes, and Costs
Sloan-Kettering Inst Can Research
FY2026$392,565R37CA264563 - Understanding the Importance of Industry Relationships for Cancer Care Quality, Outcomes, and Costs
Sloan-Kettering Inst Can Research
FY2025$392,565R37CA264563
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Beth Karlan, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”